3654 results for «372»
3654 results
Diffuse multivessel disease
05 Jul 2019 – From AICT-AsiaPCR 2019
TAVI in a bicuspid aortic valve stenosis
05 Jul 2019 – From AICT-AsiaPCR 2019
Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...
Opening - LIVE demonstration from National University Heart Centre Singapore
04 Jul 2019 – From AICT-AsiaPCR 2019
Calcified left main lesion PCI
05 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.
Complex distal left main bifurcation lesion
04 Jul 2019 – From AICT-AsiaPCR 2019
A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…
AICT-AsiaPCR Opening Ceremony
04 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations.
LAD/D1 bifurcation disease
06 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with LAD/D1 bifurcation disease.
A patient with LAD-diagonal bifurcation lesion
22 May 2019 – From EuroPCR 2019
Coronary sinus reducer for microvascular angina
28 Feb 2020
A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial
26 Oct 2023
Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.
Author
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
